These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 34298921)

  • 41. Cannabinoids - a new weapon against cancer?
    Pokrywka M; Góralska J; Solnica B
    Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1309-1320. PubMed ID: 28100841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabinoid-based drugs as anti-inflammatory therapeutics.
    Klein TW
    Nat Rev Immunol; 2005 May; 5(5):400-11. PubMed ID: 15864274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory T cells: Possible mediators for the anti-inflammatory action of statins.
    Shahbaz SK; Sadeghi M; Koushki K; Penson PE; Sahebkar A
    Pharmacol Res; 2019 Nov; 149():104469. PubMed ID: 31577918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunomodulatory Actions of Cannabinoids: Clinical Correlates and Therapeutic Opportunities for Allergic Inflammation.
    Nayak AP; Loblundo C; Bielory L
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):449-457. PubMed ID: 36280137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.
    Chiurchiù V; Leuti A; Maccarrone M
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):268-80. PubMed ID: 25601726
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Almogi-Hazan O; Or R
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic connections between autoimmune disorders and haematological malignancies.
    Javierre BM; Esteller M; Ballestar E
    Trends Immunol; 2008 Dec; 29(12):616-23. PubMed ID: 18951845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response.
    Ranieri R; Laezza C; Bifulco M; Marasco D; Malfitano AM
    Recent Pat CNS Drug Discov; 2016; 10(2):178-203. PubMed ID: 27334610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-inflammatory mechanisms of cannabinoids: an immunometabolic perspective.
    van Niekerk G; Mabin T; Engelbrecht AM
    Inflammopharmacology; 2019 Feb; 27(1):39-46. PubMed ID: 30610735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabinoids and atherosclerosis.
    Fisar Z
    Prague Med Rep; 2009; 110(1):5-12. PubMed ID: 19591373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medical Use of Cannabinoids.
    Fraguas-Sánchez AI; Torres-Suárez AI
    Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease.
    Little JP; Villanueva EB; Klegeris A
    Mini Rev Med Chem; 2011 Jun; 11(7):582-90. PubMed ID: 21699489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thymoquinone in autoimmune diseases: Therapeutic potential and molecular mechanisms.
    Ali MY; Akter Z; Mei Z; Zheng M; Tania M; Khan MA
    Biomed Pharmacother; 2021 Feb; 134():111157. PubMed ID: 33370631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabinoid agonists possibly mediate interaction between cholinergic and cannabinoid systems in regulating intestinal inflammation.
    Magalhães DA; Sousa SG; de Sousa AK; Vasconcelos DFP; Barbosa ALDR
    Med Hypotheses; 2020 Jun; 139():109613. PubMed ID: 32085982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucocorticoids and inflammation revisited: the state of the art. NIH clinical staff conference.
    Franchimont D; Kino T; Galon J; Meduri GU; Chrousos G
    Neuroimmunomodulation; 2002-2003; 10(5):247-60. PubMed ID: 12759562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of cannabinoids and leptin in neurological diseases.
    Agar E
    Acta Neurol Scand; 2015 Dec; 132(6):371-80. PubMed ID: 25880465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.